Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Colinge

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Nature Immunology|January 23, 2009
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasomeTilmann Bürckstümmer, Christoph Baumann, Stephan Blüml, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2007
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinibOliver Hantschel, Uwe Rix, Uwe Schmidt, et al.
Theranostics|March 20, 2024
Cancer-associated fibroblast spatial heterogeneity and <i>EMILIN1</i> expression in the tumor microenvironment modulate TGF-β activity and CD8<sup>+</sup> T-cell infiltration in breast cancerChikako Kanno Honda, Sasagu Kurozumi, Takaaki Fujii, et al.
Journal of Proteome Research|May 15, 2012
A comparative proteomic study of human skin suction blister fluid from healthy individuals using immunodepletion and iTRAQ labelingAndré C Müller, Florian P Breitwieser, Heinz Fischer, et al.
Nature Methods|March 5, 2013
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MSMarkku Varjosalo, Roberto Sacco, Alexey Stukalov, et al.
Journal of Proteome Research|August 2, 2013
A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsiesIvo Chamrád, Uwe Rix, Alexey Stukalov, et al.
Nature Chemical Biology|September 28, 2011
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancerMarkus K Muellner, Iris Z Uras, Bianca V Gapp, et al.
Experimental Eye Research|December 4, 2012
Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranesAndreas Pollreisz, Marion Funk, Florian P Breitwieser, et al.
Journal of Proteomics|October 14, 2010
Proteomic analysis of human cataract aqueous humour: Comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ®-labelled specimensKeiryn L Bennett, Marion Funk, Marion Tschernutter, et al.
Molecular Cancer Therapeutics|September 6, 2014
Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomicsManuela Gridling, Scott B Ficarro, Florian P Breitwieser, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Nature Immunology|January 23, 2009
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasomeTilmann Bürckstümmer, Christoph Baumann, Stephan Blüml, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2007
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinibOliver Hantschel, Uwe Rix, Uwe Schmidt, et al.
Theranostics|March 20, 2024
Cancer-associated fibroblast spatial heterogeneity and <i>EMILIN1</i> expression in the tumor microenvironment modulate TGF-β activity and CD8<sup>+</sup> T-cell infiltration in breast cancerChikako Kanno Honda, Sasagu Kurozumi, Takaaki Fujii, et al.
Journal of Proteome Research|May 15, 2012
A comparative proteomic study of human skin suction blister fluid from healthy individuals using immunodepletion and iTRAQ labelingAndré C Müller, Florian P Breitwieser, Heinz Fischer, et al.
Nature Methods|March 5, 2013
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MSMarkku Varjosalo, Roberto Sacco, Alexey Stukalov, et al.
Journal of Proteome Research|August 2, 2013
A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsiesIvo Chamrád, Uwe Rix, Alexey Stukalov, et al.
Nature Chemical Biology|September 28, 2011
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancerMarkus K Muellner, Iris Z Uras, Bianca V Gapp, et al.
Experimental Eye Research|December 4, 2012
Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranesAndreas Pollreisz, Marion Funk, Florian P Breitwieser, et al.
Journal of Proteomics|October 14, 2010
Proteomic analysis of human cataract aqueous humour: Comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ®-labelled specimensKeiryn L Bennett, Marion Funk, Marion Tschernutter, et al.
Molecular Cancer Therapeutics|September 6, 2014
Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomicsManuela Gridling, Scott B Ficarro, Florian P Breitwieser, et al.
Pageof 12